The possibility of long-term cryopreservation of cultured dermal substitute

Artificial Organs

Volumn 29, Issue 10, 2005, Pages 800-805

  Kubo, Kentaro ^a   Kuroyanagi, Yoshimitsu ^a  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Cryopreservation; Cultured dermal substitute; Fibroblasts; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MATERIALS PRESERVATION; CELL CULTURE; CELL ENGINEERING; CELL GROWTH; ENDOTHELIAL CELLS; GROWTH KINETICS; HYALURONIC ACID; STEM CELLS; THAWING; TISSUE;

CELL RELEASE; CELL VIABILITY; CLINICAL USE; CRYO-PRESERVATION; CRYOPRESERVED; CULTURED DERMAL SUBSTITUTES; FROZEN STATE; MATRIX; THERAPEUTIC EFFECTS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

FIBROBLASTS;

ATELOCOLLAGEN; HYALURONIC ACID; VASCULOTROPIN; COLLAGEN; IMMUNOLOGICAL ADJUVANT; VASCULOTROPIN A;

ALLOGENEIC CULTURED DERMAL SUBSTITUTE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; FIBROBLAST CULTURE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; PRIORITY JOURNAL; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; SKIN CULTURE; SKIN GRAFT; THAWING; ALLOTRANSPLANTATION; ARTIFICIAL SKIN; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DERMIS; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; TIME; TISSUE ENGINEERING; ULTRASTRUCTURE;

ADJUVANTS, IMMUNOLOGIC; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; CRYOPRESERVATION; DERMIS; FIBROBLASTS; HUMANS; HYALURONIC ACID; MICROSCOPY, ELECTRON, SCANNING; SKIN, ARTIFICIAL; TIME FACTORS; TISSUE ENGINEERING; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33644838348     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.00132.x     Document Type: Article

References (34)

1. Kuroyanagi Y. Advances in wound dressings and cultured skin substitutes. J Artif Organs 1999 2 : 97 116.
2. Balasubramani M Kumar TR Babu M. Skin substitutes: a review. Burns 2001 27 : 534 44.
3. Kearney JN. Clinical evaluation of skin substitutes. Burns 2001 27 : 545 51.
4. Gentzkow GD Iwasaki SD Hershon KS, et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996 19 : 350 4.
5. Hansbrough JF Mozingo DW Kealey GP Davis M Gidner A Gentzkow GD. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-transitional coverage, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997 18 : 43 51.
6. Kubo K Kuroyanagi Y. Development of cultured dermal substitute composed of hyaluronic acid and collagen combined with fibroblasts; fundamental evaluation. J Biomater Sci Polym Ed 2003 14 : 625 41.
7. Benedetti L Cortivo R Berti T Berti A Pea F. Hyaluronic acid synthetase in culture mammalian cells producing hyaluronic acid. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomater 1993 14 : 1154 8.
8. Postlethwaite AE Seyer JM Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978 75: 871 5.
9. Kuroyanagi Y Yamada N Yamashita R Uchinuma E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 2001 25 : 180 6.
10. Kuroyanagi Y Kubo K Matsui H, et al. Manufacturing and banking system for allogeneic cultured dermal substitute (Regenerative Medical Millennium Project of the Ministry of Health, Labor and Welfare). Jpn J Burn Injuries 2003 29 : 28 38.
11. Kuroyanagi Y Kubo K Matsui H, et al. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 2004 28 : 13 21.
12. Oka H Fujitsu M Suenobu K, et al. Clinical trials with allogeneic cultured dermal substitutes (CDS) for the treatment of burns and skin ulcers (Regenerative Medical Millennium Project of the Ministry of Health, Labor and Welfare). Jpn J Burn Injuries 2002 28 : 333 42.
13. Harima N Ansai S Wako M, et al. Clinical trials of allogeneic cultured dermal substitutes (CDS) for the treatment of burns and skin ulcers (Regenerative Medical Millennium Project of the Ministry of Health, Labor and Welfare). Jpn J Dermatol 2003 113 : 253 64.
14. Fujimori Y Ueda K Omiya Y Kubo K Kuroyanagi Y. Clinical trials with allogeneic cultured dermal substitutes (CDS) for full-thickness skin defects. Jpn J Plast Reconstr Surg 2003 23 : 475 84.
15. Hasegawa T Suga Y Mizoguchi M, et al. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in three patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 2004 50 : 803 4.
16. Kashiwa N Ito O Ueda T Kubo K Matsui H Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute. Artif Organs 2004 28 : 444 50.
17. Kubo K Kuroyanagi Y. Development of cultured dermal substitute composed of hyaluronic acid and collagen combined with fibroblasts; cryopreservation. Artif Organs 2004 28 : 182 8.
18. Teasdale B Sieber VK Riches DJ Nanchahal J. Cryopreservation of cultured dermal fibroblast impregnated collagen gels. Burns 1993 19 : 406 10.
19. Kearney JN. Cryopreservation of cultured skin cells. Burns 1991 17 : 380 3.
20. Kearney JN Wheldon LA Gowland G. Effects of cryobiological variables on the survival of skin using a defined murine model. Cryobiology 1990 27 : 164 70.
21. Compton CC Warland G Kratz G. Melanocytes in cultured epithelial grafts are depleted with serial subcultivation and cryopreservation: implication for clinical outcome. J Burn Care Rehabil 1998 19 : 330 6.
22. Deluca M Albanese E Bondanza S, et al. Multicenter experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns 1989 15 : 303 9.
23. Teepe RGC Koebrugg EJ Ponec M Vermeer BJ. Fresh versus cryopreserved cultured allografts for treatment of chronic skin ulcers. Br J Dermatol 1990 122 : 81 9.
24. Yanaga H Udoh Y Yamauchi T, et al. Cryopreserved cultured epidermal allografts achieved early closure of wounds and reduced scar formation in deep partial-thickness burn wound (DDB) and split-thickness skin donor sites of pediatric patients. Burns 2001 27 : 689 98.
25. Udoh Y Yanaga H Tai Y Kiyokawa K Inoue Y. Long-term viability of cryopreserved cultured epithelial grafts. Burns 2000 26 : 535 42.
26. Kubo K Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test. J Artif Organs 2003 6 : 64 70.
27. May SR DeClement FA. Skin banking methodology: an evaluation of package format, cooling and warming rates, and storage efficiency. Cryobiology 1980 17 : 33 45.
28. May SR DeClement FA. Skin banking. Cadaveric allograft skin viability. J Burn Care Rehabil 1981 2 : 128 41.
29. May SR Still JM Atkinson WB. Recent development in skin banking and the clinical uses of cryopreserved skin. J Med Assoc Ga 1984 73 : 233 6.
30. Kubo K Kuroyanagi Y. Effect of VEGF released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro. J Artif Organs 2003 6 : 267 72.
31. Nissen NN Polverini PJ Koch AE Volin MV Gamelli RL DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998 152 : 1445 52.
32. Ferrara N Henzel WJ. Pituitary follicular cell secrete a novel heparin-binding growth factor specific vascular endothelial cells. Biochem Biophys Res Commun 1989 161 : 851 8.
33. Kumar R Yoneda J Fidler IJ. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 1998 12 : 49 757.
34. ten Dijke P Iwata KK. Growth factors for wound healing. Biotechnology 1989 7 : 793 9.